Revolve Wealth Partners LLC Has $1.06 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Revolve Wealth Partners LLC raised its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 86.5% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,134 shares of the medical equipment provider’s stock after purchasing an additional 990 shares during the quarter. Revolve Wealth Partners LLC’s holdings in Intuitive Surgical were worth $1,057,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in ISRG. Atala Financial Inc acquired a new stake in Intuitive Surgical during the 4th quarter valued at $25,000. Parvin Asset Management LLC acquired a new stake in Intuitive Surgical during the 4th quarter valued at $26,000. Global Financial Private Client LLC raised its stake in Intuitive Surgical by 253.3% during the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider’s stock valued at $26,000 after purchasing an additional 38 shares during the period. BankPlus Trust Department acquired a new stake in Intuitive Surgical during the 4th quarter valued at $28,000. Finally, Hurley Capital LLC purchased a new position in shares of Intuitive Surgical during the 4th quarter valued at $28,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Intuitive Surgical

In other news, SVP Mark Brosius sold 216 shares of the company’s stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $563.11, for a total transaction of $121,631.76. Following the completion of the transaction, the senior vice president now owns 907 shares of the company’s stock, valued at approximately $510,740.77. This represents a 19.23% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Robert Desantis sold 11,545 shares of the company’s stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the transaction, the executive vice president now directly owns 5,224 shares of the company’s stock, valued at $2,607,925.28. This represents a 68.85% decrease in their position. The disclosure for this sale can be found here. Insiders sold 25,443 shares of company stock worth $12,692,195 over the last ninety days. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Trading Down 0.2%

Shares of NASDAQ:ISRG opened at $557.08 on Friday. Intuitive Surgical, Inc. has a 1 year low of $413.52 and a 1 year high of $616.00. The firm has a fifty day moving average price of $521.99 and a 200 day moving average price of $539.24. The stock has a market capitalization of $199.67 billion, a PE ratio of 86.91, a P/E/G ratio of 5.85 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The company had revenue of $2.25 billion during the quarter, compared to analysts’ expectations of $2.19 billion. During the same period in the prior year, the company earned $1.50 earnings per share. On average, sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research firms have recently commented on ISRG. Barclays lowered their price target on shares of Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating on the stock in a report on Thursday, April 24th. BTIG Research set a $560.00 price target on shares of Intuitive Surgical and gave the company a “buy” rating in a report on Monday, April 14th. Citigroup restated a “buy” rating and set a $650.00 price target (up from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Thursday. Finally, Evercore ISI lowered their price target on shares of Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating on the stock in a report on Wednesday, April 23rd. Four research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average target price of $596.05.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.